Home
 /
Papers
 /
Molecular Biology
 /
Transcription directs Holliday junction branch migration
Preprint
Open access
V1
Top 1% · Validated by QED

Transcription directs Holliday junction branch migration

Tom J. Powell, George G. B. Brown, Rachal M. Allison +3 more
March 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.03.13.711646
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Molecular Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By delivering the first nucleotide-resolution genome-wide map of Top3 activity, this paper establishes that transcription actively drives Holliday junction migration to cohesin-rich axis sites, fundamentally reframing how chromosome architecture directs crossover resolution.

QED claims analysis

Summary

Transcription directs the migration of crossover-designated Holliday junctions from Spo11 hotspots toward cohesin-associated chromosome axis sites at convergent transcription regions, where crossover resolution preferentially occurs, thereby coordinating the molecular events of meiotic recombination with chromosome architecture to ensure accurate chromosome segregation.

See full analysis
Main Claim 1 –

CC-seq Maps Meiotic Top3 Catalysis at Nucleotide Resolution

Main Claim 2 –

Transcription-Directed Top3 Migration to Convergent Axis Sites

Supporting evidence

  • Cohesin Enables Top3 Accumulation at Convergent Transcription Sites
  • Mer3 and Msh5 Are Required for Top3 Axisward Migration
Main Claim 3 –

Crossovers Preferentially Resolve at Convergent Transcription Sites

Supporting evidence

  • Integrated Model: MTR, Cohesin, Transcription Drive Holliday Junction Migration

Abstract

During meiosis, genetic diversity arises from the resolution of branched DNA intermediates called Holliday junctions to create crossovers—sites of reciprocal exchange between parental chromosomes. Holliday junctions arise during the repair of Spo11-induced DNA breaks, yet the principles linking break formation, repair, and chromosome architecture remain unclear. Top3, a type IA topoisomerase, acts on Holliday junctions, but its spatiotemporal dynamics are unknown. Here, we map Top3 catalytic activity throughout meiotic prophase with strand specificity and nucleotide resolution. We identify a DNA sequence motif associated with catalysis and a pattern of activity around Spo11 hotspots that requires ongoing repair and Top3’s helicase partner, Sgs1. Strikingly, Top3 activity shifts over time, influenced by transcription, cohesin, and the crossover factors Msh5 and Mer3, redistributing toward sites of convergent transcription—known locations of meiotic cohesin association. Upon prophase exit, as crossovers are resolved, Top3 activity subsides. Remarkably, maps of genome-wide recombination reveal that crossover resolution preferentially occurs at these same regions of convergent transcription. Collectively, we propose that Top3 coordinates the transcription-coupled movement of Holliday junctions from Spo11 hotspots towards cohesin-associated axis sites, whereupon crossover resolution occurs to ensure accurate meiotic chromosome segregation.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?